by: Jason Stoogenke, WSOCTV.com
The company behind the EpiPen, a life-saving drug delivery device for severe allergic reactions, recalled some sets of the auto-injector abroad on Monday, although none were recalled in the U.S.
Pharmaceutical company Mylan said in a recall notice that one batch of EpiPens might not work properly. The batch went to Australia, New Zealand, Europe and Japan. The company voluntarily recalled those.
Mylan said that it got two reports worldwide of EpiPens to activate out of a batch of 80,000 devices. The issue came from a defective part, the company said.
Mylan came under fire recently for raising the price of the EpiPen to $600. The cost amounts to a 400 percent increase in price between 2007, when Mylan acquired the devices, and 2016.
The Cox Media Group National Content Desk contributed to this report.